Web Stats Provided By Google Analytics

The Raw Stem Cell News Feed

The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research

Saturday, December 6, 2014

ImmunoGen, Inc. Announces Encouraging IMGN529 Clinical Data Presented ...

These include objective responses at doses that were generally well tolerated. ImmunoGen's IMGN529 is a potential new treatment for DLBCL and other non-Hodgkin lymphoma subtypes.

http://ift.tt/1s69Fkj

No comments:

Post a Comment

Popular Stem Cell Roundup Posts